{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:25:08Z","timestamp":1759047908860},"reference-count":22,"publisher":"Elsevier BV","issue":"5-6","license":[{"start":{"date-parts":[[2004,1,1]],"date-time":"2004-01-01T00:00:00Z","timestamp":1072915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2004,1]]},"DOI":"10.1016\/j.thromres.2004.06.016","type":"journal-article","created":{"date-parts":[[2004,7,23]],"date-time":"2004-07-23T14:54:10Z","timestamp":1090594450000},"page":"477-481","source":"Crossref","is-referenced-by-count":18,"title":["The interface of multiple sclerosis and antiphospholipid antibodies"],"prefix":"10.1016","volume":"114","author":[{"given":"Joab","family":"Chapman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2004.06.016_BIB1","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/ana.410440408","article-title":"A subgroup of multiple sclerosis patients with anticardiolipin antibodies and unusual clinical manifestations: Do they represent a new nosological entity?","volume":"44","author":"Karussis","year":"1998","journal-title":"Ann. Neurol"},{"key":"10.1016\/j.thromres.2004.06.016_BIB2","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1006\/jaut.2000.0367","article-title":"Prevalence and clinical significance of anti-phospholipid antibodies in multiple sclerosis: A study of 89 patients","volume":"14","author":"Roussel","year":"2000","journal-title":"J. Autoimmun"},{"key":"10.1016\/j.thromres.2004.06.016_BIB3","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1620\/tjem.178.203","article-title":"Characterization of serum anti-phospholipid antibodies in patients with multiple sclerosis","volume":"178","author":"Sugiyama","year":"1996","journal-title":"Tohoku J. Exp. Med"},{"key":"10.1016\/j.thromres.2004.06.016_BIB4","first-page":"635","article-title":"Multiple sclerosis and antiphospholipid antibodies: Study of 62 consecutive patients","volume":"19","author":"Cordoliani","year":"1998","journal-title":"Rev. Med. Intern.\/Fond. Soc. Natl. Fr. Med. Int"},{"key":"10.1016\/j.thromres.2004.06.016_BIB5","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1001\/archneur.55.4.517","article-title":"Systemic autoimmune features and multiple sclerosis: A 5-year follow-up study","volume":"55","author":"Tourbah","year":"1998","journal-title":"Arch. Neurol"},{"key":"10.1016\/j.thromres.2004.06.016_BIB6","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1212\/WNL.51.5.1376","article-title":"Specificity, isotype, and titer distribution of anticardiolipin antibodies in CNS diseases","volume":"51","author":"D'Olhaberriague","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.thromres.2004.06.016_BIB7","first-page":"556","article-title":"Lupus anticoagulant: correlation with magnetic resonance imaging of brain lesions","volume":"19","author":"Molad","year":"1992","journal-title":"J. Rheumatol"},{"key":"10.1016\/j.thromres.2004.06.016_BIB8","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0022-510X(02)00271-X","article-title":"Prevalence and clinical features of dementia associated with the antiphospholipid syndrome and circulating anticoagulants","volume":"203\u2013204","author":"Chapman","year":"2002","journal-title":"J. Neurol. Sci"},{"key":"10.1016\/j.thromres.2004.06.016_BIB9","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0022-510X(01)00468-3","article-title":"Plasma thrombin\u2013antithrombin III complex is associated with the severity of experimental autoimmune encephalomyelitis","volume":"185","author":"Inaba","year":"2001","journal-title":"J. Neurol. Sci"},{"key":"10.1016\/j.thromres.2004.06.016_BIB10","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1600-0897.1997.tb00200.x","article-title":"Induction of experimental antiphospholipid antibody syndrome in PL\/J mice following immunization with beta 2 GPI","volume":"37","author":"Garcia","year":"1997","journal-title":"Am. J. Reprod. Immunol"},{"key":"10.1016\/j.thromres.2004.06.016_BIB11","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1191\/0961203302lu255oa","article-title":"Behavioral and cognitive deficits occur only after prolonged exposure of mice to antiphospholipid antibodies","volume":"11","author":"Shrot","year":"2002","journal-title":"Lupus"},{"key":"10.1016\/j.thromres.2004.06.016_BIB12","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S0022-510X(00)00325-7","article-title":"Cervical cord magnetic resonance imaging findings in systemic immune-mediated diseases","volume":"176","author":"Rovaris","year":"2000","journal-title":"J. Neurol. Sci"},{"key":"10.1016\/j.thromres.2004.06.016_BIB13","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1136\/jnnp.68.2.170","article-title":"Brain involvement in systemic immune mediated diseases: Magnetic resonance and magnetisation transfer imaging study","volume":"68","author":"Rovaris","year":"2000","journal-title":"J. Neurol., Neurosurg., Psychiatry"},{"key":"10.1016\/j.thromres.2004.06.016_BIB14","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/mrm.10040","article-title":"High b-value q-space analyzed diffusion-weighted MRI: Application to multiple sclerosis","volume":"47","author":"Assaf","year":"2002","journal-title":"Magn. Reson. Med"},{"key":"10.1016\/j.thromres.2004.06.016_BIB15","first-page":"1113","article-title":"An electrophysiological study and brain MRI evaluation of patients with CNS manifestations of the antiphospholipid syndrome as compared to patients with multiple sclerosis","volume":"48","author":"Paran","year":"2003","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.thromres.2004.06.016_BIB16","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/00005792-200001000-00006","article-title":"Can neurological manifestations of Hughes (antiphospholipid) syndrome be distinguished from multiple sclerosis? Analysis of 27 patients and review of the literature","volume":"79","author":"Cuadrado","year":"2000","journal-title":"Medicine"},{"key":"10.1016\/j.thromres.2004.06.016_BIB17","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1191\/096120399678847461","article-title":"Anti-phospholipid antibodies in patients with multiple sclerosis and MS-like illnesses: MS or APS?","volume":"8","author":"IJdo","year":"1999","journal-title":"Lupus"},{"key":"10.1016\/j.thromres.2004.06.016_BIB18","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1172\/JCI113953","article-title":"Suppression of experimental autoimmune diseases and prolongation of allograft survival by treatment of animals with low doses of heparins","volume":"83","author":"Lider","year":"1989","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.thromres.2004.06.016_BIB19","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/qjmed\/93.8.497","article-title":"Warfarin for multiple sclerosis?","volume":"93","author":"Ruiz_Irastorza","year":"2000","journal-title":"QJM: Mon. J. Assoc. Phys"},{"key":"10.1016\/j.thromres.2004.06.016_BIB20","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1084\/jem.20021996","article-title":"Type-I interferon receptor deficiency reduces lupus-like disease in NZB mice","volume":"197","author":"Santiago-Raber","year":"2003","journal-title":"J. Exp. Med"},{"key":"10.1016\/j.thromres.2004.06.016_BIB21","first-page":"S57","article-title":"Serum auto antibodies presence in multiple sclerosis patients treated with beta-interferon 1a and 1b","volume":"6","author":"Speciale","year":"2000","journal-title":"J. Neurovirol"},{"key":"10.1016\/j.thromres.2004.06.016_BIB22","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/j.1600-0404.1997.tb00300.x","article-title":"No increase of serum autoantibodies during therapy with recombinant human interferon-beta1a in relapsing\u2013remitting multiple sclerosis","volume":"96","author":"Colosimo","year":"1997","journal-title":"Acta Neurol. Scand"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384804003238?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384804003238?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,5]],"date-time":"2019-02-05T14:28:30Z","timestamp":1549376910000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384804003238"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,1]]},"references-count":22,"journal-issue":{"issue":"5-6","published-print":{"date-parts":[[2004,1]]}},"alternative-id":["S0049384804003238"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2004.06.016","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2004,1]]}}}